Literature DB >> 12114747

Pheochromocytoma in von hippel-lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2.

Christian A Koch1, David Mauro, McClellan M Walther, W Marston Linehan, Alexander O Vortmeyer, Ronald Jaffe, Karel Pacak, George P Chrousos, Zhengping Zhuang, Irina A Lubensky.   

Abstract

Pheochromocytomas are rare neuroendocrine tumors that arise from chromaffin tissue. In a small subset of patients, pheochromocytomas occur as a manifestation of von Hippel- Lindau (VHL) disease. The histology of VHL-associated pheochromocytomas has not been reported in detail. In this article, we describe histopathologic features of 14 pheochromocytomas in eight patients with VHL disease and demonstrate that VHL-associated pheochromocytomas have a distinct histologic phenotype as compared with pheochromocytomas in patients with multiple endocrine neoplasia type 2 (MEN 2). VHL tumors are characterized by a thick vascular tumor capsule; myxoid and hyalinized stroma; round, small to medium tumor cells intermixed with small vessels; predominantly amphophilic and clear cytoplasm; absence of cytoplasmic hyaline globules; and lack of nuclear atypia or mitoses. In contrast to MEN 2, there is no extratumoral adrenomedullary hyperplasia in the VHL adrenal gland. Our findings of a distinct histologic phenotype of VHL pheochromocytoma may further help in subdividing patients who clinically present with multiple, bilateral pheochromocytomas.

Entities:  

Mesh:

Year:  2002        PMID: 12114747     DOI: 10.1385/ep:13:1:17

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  51 in total

Review 1.  Seminars in medicine of the Beth Israel Hospital, Boston. The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease.

Authors:  C Eng
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

2.  Hippel-Lindau disease: MR imaging.

Authors:  Y Sato; M Waziri; W Smith; E Frey; W T Yuh; J Hanson; E A Franken
Journal:  Radiology       Date:  1988-01       Impact factor: 11.105

Review 3.  Genetic aspects of pheochromocytoma.

Authors:  C A Koch; A O Vortmeyer; S C Huang; S Alesci; Z Zhuang; K Pacak
Journal:  Endocr Regul       Date:  2001-03

4.  Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.

Authors:  G Eisenhofer; J W Lenders; W M Linehan; M M Walther; D S Goldstein; H R Keiser
Journal:  N Engl J Med       Date:  1999-06-17       Impact factor: 91.245

5.  Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes.

Authors:  G Eisenhofer; M M Walther; T T Huynh; S T Li; S R Bornstein; A Vortmeyer; M Mannelli; D S Goldstein; W M Linehan; J W Lenders; K Pacak
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

6.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

7.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

Review 8.  Multiple endocrine neoplasia, type 2b.

Authors:  J A Carney; G W Sizemore; A B Hayles
Journal:  Pathobiol Annu       Date:  1978

9.  The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis.

Authors:  V Kalff; B Shapiro; R Lloyd; J C Sisson; K Holland; M Nakajo; W H Beierwaltes
Journal:  Arch Intern Med       Date:  1982-11

10.  Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia.

Authors:  L M DeAngelis; M B Kelleher; K D Post; M R Fetell
Journal:  Neurology       Date:  1987-01       Impact factor: 9.910

View more
  11 in total

Review 1.  Von Hippel-Lindau disease: a single gene, several hereditary tumors.

Authors:  J Crespigio; L C L Berbel; M A Dias; R F Berbel; S S Pereira; D Pignatelli; T L Mazzuco
Journal:  J Endocrinol Invest       Date:  2017-06-06       Impact factor: 4.256

Review 2.  [Tumors of the adrenal medulla and the paraganglia].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2003-05-29       Impact factor: 1.011

3.  Neuropeptide Y expression in phaeochromocytomas: relative absence in tumours from patients with von Hippel-Lindau syndrome.

Authors:  Susannah Cleary; Jacqueline K Phillips; Thanh-Truc Huynh; Karel Pacak; Abdel G Elkahloun; Jennifer Barb; Robert A Worrell; David S Goldstein; Graeme Eisenhofer
Journal:  J Endocrinol       Date:  2007-05       Impact factor: 4.286

4.  Histologic and immunohistochemical characterization of pheochromocytoma in 6 cotton-top tamarins (Saguinus oedipus).

Authors:  A D Miller; K Masek-Hammerman; K Dalecki; K G Mansfield; S V Westmoreland
Journal:  Vet Pathol       Date:  2009-07-15       Impact factor: 2.221

Review 5.  Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 6.  Von Hippel-Lindau Disease: Current Challenges and Future Prospects.

Authors:  Sven Gläsker; Evelynn Vergauwen; Christian A Koch; Alexander Kutikov; Alexander O Vortmeyer
Journal:  Onco Targets Ther       Date:  2020-06-16       Impact factor: 4.147

7.  Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations.

Authors:  D J Pinato; R Ramachandran; S T K Toussi; M Vergine; N Ngo; R Sharma; T Lloyd; K Meeran; F Palazzo; N Martin; B Khoo; R Dina; T M Tan
Journal:  Br J Cancer       Date:  2012-12-20       Impact factor: 7.640

8.  Familial pheochromocytomas and paragangliomas: stories from the sign-out room.

Authors:  Aurel Perren; Paul Komminoth
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

Review 9.  Molecular and cellular biology of pheochromocytomas and extra-adrenal paragangliomas.

Authors:  Arthur S Tischler
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

10.  Mosaicism in von Hippel-Lindau disease: an event important to recognize.

Authors:  Libero Santarpia; Nicholas J Sarlis; Mariacarmela Santarpia; Steven I Sherman; Francesco Trimarchi; Salvatore Benvenga
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.